Wall Street equity analysts covering TerrAscend maintain consensus twelve-month price targets averaging approximately $1.40 to $1.50 per share, with individual forecasts reflecting potential upside depending on market sentiment. These valuation projections are updated periodically by financial research institutions based on quarterly revenue growth, gross margin expansion, regulatory developments in federal cannabis reform, and broader macroeconomic conditions impacting the North American cannabis sector.